MISSISSAUGA, Ontario, Dec. 8, 2009 (GLOBE NEWSWIRE) -- Hydrogenics Corporation (TSX:HYG) (Nasdaq:HYGS), a leading developer and manufacturer of hydrogen generation and fuel cell products, today announced that it has delivered another fuel-cell powered Midibus based on the Tecnobus S.p.A electric bus platform for operation at a hospital complex in Hamburg, Germany. This vehicle, the eleventh such Midibus in operation, is owned by Klinik Logistic Eppendorf GmbH, a division of University Klinik Eppendorf. The purchase was coordinated through HySolutions GmbH, a company that promotes the use of fuel cells and hydrogen, and sponsored by the City-State of Hamburg. The project also received support via the National Innovation Program (NIP) of hydrogen and fuel cell technology from the Nationale Organisation Wasserstoff (NOW) and the German Federal Ministry of Transport, Building and Urban Development.
"The Hydrogenics Midibus continues to gain traction across the continent as local governments come to view it as an appropriate solution for urban, emission-sensitive environments," said Daryl Wilson, President and CEO. "With eleven such buses now delivered and in use, Hydrogenics has validated its unique fuel cell applications and energy-efficient mobility design with a high degree of reliability, paving the way for future awards. Europe clearly plays a large role in clean transportation solutions, and we are well positioned for further growth there."
ABOUT HYDROGENICS
Hydrogenics Corporation (www.hydrogenics.com) is a globally recognized developer and provider of hydrogen generation and fuel cell products and services, serving the growing industrial and clean energy markets of today and tomorrow. Based in Mississauga, Ontario, Canada, Hydrogenics has operations in North America and Europe.
This release contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Law of 1995. These statements are based on management's current expectations and actual results may differ from these forward-looking statements due to numerous factors, including changes in the competitive environment adversely affecting the products, markets, revenues or margins of Hydrogenics' business. Readers should not place undue reliance on Hydrogenics' forward-looking statements. Investors are encouraged to review the section captioned "Risk Factors" in Hydrogenics' regulatory filings with the Canadian securities regulatory authorities and the United States Securities and Exchange Commission for a more complete discussion of factors that could affect Hydrogenics' future performance. Furthermore, the forward-looking statements contained herein are made as of the date of this release, and Hydrogenics undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release. The forward-looking statements contained in this release are expressly qualified by this.